Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 15 June 2021, 10:59 HKT/SGT
Share:
    

Source: Fujitsu Ltd
Fujitsu to Initiate On-Site Vaccinations for Employees in Japan

TOKYO, June 15, 2021 - (JCN Newswire) - Fujitsu Limited today announced that in accordance with the Japanese government's COVID-19 vaccination policy targeting a June 21, 2021 start for large companies and universities, Fujitsu will initiate on-site inoculations for employees at select locations in Japan from June 29, 2021, supplementing efforts by local governments. COVID-19 vaccinations will start in areas with at least 1,000 employees and where vaccinations can be administered by in-house medical staff. Beginning with Fujitsu's Kawasaki Plant, Fujitsu plans to offer vaccinations to over 1,000 employees per day to fully vaccinate 30,000 employees by October 2021 (60,000 doses). As soon as preparations are made, Fujitsu plans to expand the initiative to other areas, including its Kansai Systems Laboratory.

Additionally, if Fujitsu Group employees receive vaccinations at work or from their local municipality on a working day, special measures will be taken to permit them to take accumulated leave as vaccine leave. This will make it easier for employees, who can take advantage of flextime and remote working, to flexibly schedule their vaccinations. Accumulated leave can also be taken when it becomes difficult to work due to adverse reactions to the vaccine, or when it is necessary to attend to the vaccination of a family member or to take care of a family member recovering from side effects.

Prevention of future outbreaks of COVID-19 will require swift action to ensure that as many people as possible can safely and smoothly receive their vaccinations. Bearing this in mind, in addition to its efforts to vaccinate its employees, the Fujitsu Group will also offer vaccinations to residents in its local communities, for instance with its ongoing program to offer inoculations for city residents at its Fujitsu Clinic in the City of Kawasaki.

By contributing proactively to the Japanese government's target of 1 million vaccinations per day, the Fujitsu Group aims to ease the burden on all involved, while creating an environment in which people can work in good health, with peace of mind and body.

Work Site Vaccination Program Overview
Starting Date: Upon completion of preparations from June 29, 2021
Location: Fujitsu's Kawasaki Plant, Kansai Systems Laboratory
Target: Fujitsu Group employees that wish to receive their vaccine
No. of vaccines: Over 1,000 people a day, for 30,000 staff vaccinated on-site by October 2021.
Vaccine Type: Moderna (manufactured by Takeda Pharmaceutical Company Limited) vaccine distributed by the Japanese Government
Additional considerations: Encouraging use of flextime and remote work, accumulated leave

About Fujitsu

Fujitsu is the leading Japanese information and communication technology (ICT) company offering a full range of technology products, solutions and services. Approximately 126,000 Fujitsu people support customers in more than 100 countries. We use our experience and the power of ICT to shape the future of society with our customers. Fujitsu Limited (TSE:6702) reported consolidated revenues of 3.6 trillion yen (US$34 billion) for the fiscal year ended March 31, 2021. For more information, please see www.fujitsu.com.


Topic: Press release summary
Source: Fujitsu Ltd

Sectors: Cloud & Enterprise, Local Biz
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Fujitsu Ltd Links

http://www.fujitsu.com

https://plus.google.com/+Fujitsu

https://www.facebook.com/FujitsuJapan

https://twitter.com/Fujitsu_Global

https://www.youtube.com/user/FujitsuOfficial

https://www.linkedin.com/company/fujitsu/

Fujitsu Ltd
Aug 1, 2025 09:20 HKT/SGT
Fujitsu starts official development of plus-10,000 qubit superconducting quantum computer targeting completion in 2030
July 24, 2025 11:30 HKT/SGT
Fujitsu and Nagoya University develop simulation tech to combat transportation gaps
July 16, 2025 09:30 HKT/SGT
Fujitsu Data Intelligence PaaS enhances Mazda's data-utilization and decision-making
July 16, 2025 09:20 HKT/SGT
Fujitsu and Acer Medical trial AI service that assesses future disease risk in elderly patients through gait pattern abnormality detection
July 14, 2025 09:30 HKT/SGT
Fujitsu's AI-powered supply chain solution selected as transformative example of applied-AI technology by World Economic Forum
July 5, 2025 12:40 HKT/SGT
Fujitsu's high-precision skeleton recognition AI adopted to enhance figure skating athlete training
July 4, 2025 12:19 HKT/SGT
Fujitsu to implement store monitoring solution for METRO Inc. in Canada, enhancing operational efficiency and policy compliance
July 3, 2025 10:14 HKT/SGT
Fujitsu to develop ETF trading platform based on TSE's CONNEQTOR and provide it to Australian Securities Exchange
July 2, 2025 10:32 HKT/SGT
Fujitsu launches solution to enhance customers' global supply chain resilience
July 1, 2025 21:53 HKT/SGT
1Finity, a Fujitsu company, commences operations and reveals brand identity
More news >>
 News Alerts
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: